Veradermics Earnings
NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
130.90+4.27 (+3.37%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Veradermics earnings summary
In its most recent report on Aug 11, 2026 (Q2 2026), MANE posted EPS of $-0.58.
Summary generated from market data by MetaCap's automated system. Methodology
MANE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2026 | — | $-0.58 | — | -8.8% |
| May 12, 2026 | — | $-1.32 | — | +1.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.